Healthy Investments Board of Directors

Get the latest insights into the leadership at Healthy Investments. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Ms. Rukmini Devi Satuluri Director & CEO
Mr. Kameswara Sharma Chavali Non Executive Director
Mr. Krishna Babu Cherukuri Non Executive Director
Mr. Revathi Raghunathan Independent Director
Mr. Subramanian Neelakantan Independent Director

Healthy Investments Share price

HEALINV

3.2

0.00 (0.00%)
Last updated on 30 Sep, 2025 | 16:00 IST
BUYSELL
Today's High

00

Today's Low

00

52 Week Low

0.00

52 Week High

0.00

The current prices are delayed, login to your account for live prices

Healthy Investments FAQs

The board at Healthy Investments consists of experienced professionals, including Ms. Rukmini Devi Satuluri , Mr. Kameswara Sharma Chavali , and others, overseeing the company’s strategic and corporate governance.

Directors at Healthy Investments are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Ms. Rukmini Devi Satuluri is the current chairman at Healthy Investments.

Executive directors at Healthy Investments are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Healthy Investments adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Healthy Investments, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.